je.st
news
Merck Raises 2013 Profit Forecast on Progress in Cost Cuts
2013-11-15 02:03:46| Biotech - Topix.net
Merck KGaA, the German maker of the cancer drug Erbitux, raised its profit forecast for the year as cost reductions are taking effect faster than planned.
Tags: cost
progress
profit
cuts
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||